KIRLYNXA Trademark

Trademark Overview

On Friday, February 3, 2017, a trademark application was filed for KIRLYNXA with the United States Patent and Trademark Office. The USPTO has given the KIRLYNXA trademark a serial number of 87323560. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 21, 2020. This trademark is owned by AbbVie Inc.. The KIRLYNXA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
kirlynxa

General Information

Serial Number87323560
Word MarkKIRLYNXA
Filing DateFriday, February 3, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 21, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, September 21, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 21, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, March 2, 2020ASSIGNED TO EXAMINER
Thursday, January 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2020EXTENSION 5 GRANTED
Friday, January 24, 2020EXTENSION 5 FILED
Wednesday, January 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 24, 2020TEAS EXTENSION RECEIVED
Friday, August 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2019EXTENSION 4 GRANTED
Wednesday, August 14, 2019EXTENSION 4 FILED
Wednesday, August 14, 2019TEAS EXTENSION RECEIVED
Friday, February 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 13, 2019EXTENSION 3 GRANTED
Wednesday, February 13, 2019EXTENSION 3 FILED
Wednesday, February 13, 2019TEAS EXTENSION RECEIVED
Friday, August 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 1, 2018EXTENSION 2 GRANTED
Wednesday, August 1, 2018EXTENSION 2 FILED
Wednesday, August 1, 2018TEAS EXTENSION RECEIVED
Thursday, February 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2018EXTENSION 1 GRANTED
Tuesday, February 13, 2018EXTENSION 1 FILED
Tuesday, February 13, 2018TEAS EXTENSION RECEIVED
Tuesday, August 15, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 31, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, April 30, 2017ASSIGNED TO EXAMINER
Wednesday, February 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 7, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

kirlynxa gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related